The six months expired in Oct 2015.GVHD had not received full marketing approval so there is one and the other is the first report of the phase 2 trial on rheumatoid arthritis which is due any day now!That's why they asked for a six month extension aswell as to do further due diligence on the applications.
Stem cells therapy, page-101
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.030(2.01%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $12.79M | 8.551M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5920 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 44324 | 9 |
View Market Depth
| Last trade - 13.12pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |